“In Silico Evaluation of Natural Chalcones As Aromatase and EGFR Tyrosine Kinase Inhibitors to Combat Breast and Ovarian Cancers”. Vascular and Endovascular Review 8, no. 9s (November 14, 2025): 120–131. Accessed June 28, 2026. https://verjournal.com/index.php/ver/article/view/729.